Zhu Xiao-ming
Title:
Director of Department of Research and Education Chief Physician
Bio:
Education:
2003-2006 Zhejiang University PhD
1985-1988 Shandong University MS
1978-1982 Nantong University MD
Expertise:
Assisted reproduction
Reproductive safety
Prevention & control of birth defects
Research Interests:
Reproductive aging
Assisted reproduction
Reproductive safety
Prevention & control of birth defects
Research Narrative:
l Participating: Demonstration and application of key techniques and intervention specifications for screening and diagnosis of birth defects, granted from The National Key R&D Program, the Ministry of Science & Technology, China (2018-2020, No. 2018YFC1002703)
l Participating: Risk assessment of embryo-fetus-originated adult diseases resulted from assisted reproduction and research on the related mechanisms, granted from The National Basic Research Program, the Ministry of Science & Technology, China (2012-2016, No. 2012CB944900)
l Operating: Study on the changes of expression profiles of genomic imprints in the low-birth-body-weight offspring born following assisted reproduction techniques and the related molecular mechanisms, granted from The National Natural Science Fund of China (2011-2013, No. 81070541)
l Participating: Role of oocyte-derived growth factors in human ovarian follicle development, granted from China-Canada Joint Health Res (2008-2010, No. 30711120577)
l Operating: The dynamic investigation of genomic imprints expression profiles and changes of assisted conceptions and the related mechanisms, granted from The National Natural Science Fund of China (2007-2009, No. 30671161)
l The main results have been published in journals covered by SCI and the related achievements in reproductive safety and the prevention & control of birth defects were awarded in 2015 by China Maternal & Child Health Association.
Publication:
1. Soman M, Huang LC, Cai WH, Xu JB, Chen JY, He RK, Ruan HC, Xu XR, Qian ZD, Zhu XM*: Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis. Menopause. 2019; 26(1):78-93
2. Qian ZD, Wang Y, Wang CF, Huang LL, Zhu XM*: Research on the expression of integrin β3 and leukemiainhibitory factor in the decidua of women with cesarean scar pregnancy. BMC Pregnancy Childbirth 2017; 17(1):84
3. Qian ZD, Huang LL, Zhu XM*: Curettage or operative hysteroscopy in the treatment of cesarean scar pregnancy. Arch Gynecol Obstet 2015; 292(5):1055-61
4. Qian ZD, Huang LL, Zhu XM*: An immunohistochemical study of CD83- and CD1a-positive dendritic cells in the decidua of women with recurrent spontaneous abortion. Eur J Med Res 2015, 20:2
5. Qian ZD, Zhu XM*: Caesarean scar choriocarcinoma: a case report and review of the literature. Eur J Med Res 2014, 19:5.
6. He RH, Zhu XM (Corresponding author), How to deal with fluid in the endometrial cavity during assisted reproductive techniques. CurrOpin Obstet Gynecol. 2011; 23(3):190-4.
7. He RH, Gao HJ, Li YQ, and Zhu XM (Corresponding author), The associated factors to endometrial cavity fluid and the relevant impact on the IVF-ET outcome. Reprod Biol Endocrinol, 2010. 8:46.
8. Zhu XM, Zhu YM, Huang HF, et al: Autologous mature follicular fluid: its role in in vitro maturation of human cumulus-removed oocytes. Fertil Steril, 2008; 90(4):1094-102.
9. Jin L, Zhu X M, Huang H F, et al: A novel SNP at exon 17 of the INSR gene is associated with decreased insulin sensitivity in the Chinese women with PCOS. Mol Hum Reprod 2006, 12(3):151-155.
10. Ruan H C, Zhu X M, Huang H F., et al: Ovarian stimulation with GnRHa, but not GnRHant, might restore the expression of endometrial integrin β3 and leukemia inhibitory factor and improve uterine receptivity in mice. Hum Reprod, 2006, 21(10):2521-2529
Personal Homepage:
https://person.zju.edu.cn/en/ntzhuxm